BioNTech

NEWS

Policy

Biopharma Update on the Novel Coronavirus: September 14

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 14, 2020.

September 14, 2020

3 min read

BioSpace Editorial Staff

Drug Development

Preclinical Data Supports Efficacy for Pfizer, BioNTech Phase II/III COVID-19 Vaccine

Preclinical data for Pfizer and BioNTech’s Phase II/III COVID-19 mRNA vaccine candidate generated BNT162b2 strong anti-viral effects against an infectious SARS-CoV-2 challenge.

September 9, 2020

3 min read

Alex Keown

BioCapital

CEOs Pledge to Stand Behind Science, Not Politics in Potential Vaccine Approval

The CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Moderna, Novavax, Pfizer, Merck and Sanofi all signed the pledge promising to ensure that any vaccine put forth by one or more of the companies meets the rigorous standards for approval.

September 8, 2020

3 min read

Alex Keown

Policy

Biopharma Update on the Novel Coronavirus: September 9

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 9, 2020.

September 8, 2020

4 min read

BioSpace Editorial Staff

Drug Development

Clinical Catch-Up: August 17-21

It was a relatively quiet week for clinical trial news. Here’s a look.

August 21, 2020

5 min read

Mark Terry

Drug Development

Pfizer and BioNTech Release Additional Early-Stage Data on COVID-19 Vaccine

Today’s data describes key safety and immunogenicity data from the U.S. Phase I study for BNT162b.

August 21, 2020

3 min read

Mark Terry

Policy

Biopharma Update on the Novel Coronavirus: August 21

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 21, 2020.

August 20, 2020

5 min read

BioSpace Editorial Staff

Policy

Biopharma Update on the Novel Coronavirus: August 12

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 12, 2020.

August 11, 2020

5 min read

BioSpace Editorial Staff

BioCapital

Clinical Catch-Up: August 3-7

It was a moderately busy week for clinical trial news, with some particularly interesting announcements related COVID-19 vaccine trials. Here’s a look.

August 6, 2020

8 min read

Mark Terry